Autonomic dysreflexia is a condition that develops after spinal cord injury
in which potentially life-threatening episodic hypertension is triggered b
y stimulation of sensory nerves in the body below the site of injury. Centr
al sprouting of small-diameter primary afferent fibers in the dorsal horn o
f the spinal cord occurs concurrently with the development of this conditio
n. We propose a model for the development of autonomic dysreflexia in which
increased nerve growth factor (NGF) in the injured cord stimulates small-d
iameter primary afferent fiber sprouting, thereby magnifying spinal sympath
etic reflexes and promoting dysreflexia. We identified this population of a
fferent neurons using immunocytochemistry for calcitonin gene-related pepti
de. Blocking intraspinal NGF with an intrathecally-delivered neutralizing a
ntibody to NGF prevented small-diameter afferent sprouting in rats 2 weeks
after a high thoracic spinal cord transection. In the same rats, this anti-
NGF antibody treatment significantly decreased (by 43%) the hypertension in
duced by colon stimulation. The extent of small-diameter afferent sprouting
after cord transection correlated significantly with the magnitude of incr
eases in arterial pressure during the autonomic dysreflexia. Neutralizing N
GF in the spinal cord is a promising strategy to minimize the life-threaten
ing autonomic dysreflexia that develops after spinal cord injury.